SCHEMBL4066635

SCHEMBL4066635

CON(C)C(=O)c1ccc2nnn(C)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.51
HCAR3 P49019 1/20 0.48
MAPT P10636 3/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
AHR P35869 1/20 0.41
RAB9A P51151 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CHRM4 P08173 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MLYCD O95822 1/20 0.40
SLC9A1 P19634 1/20 0.39
KEAP1 Q14145 1/20 0.39
NOTUM Q6P988 1/20 0.39
NPC1 O15118 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741825 0.83 HCAR3 (0.54) HPGDHCAR3MLYCD
SCHEMBL2884485 0.80 HCAR3 (0.53) HPGDHCAR3MAPTPOLBSMN1; SMN2
SCHEMBL29809047 0.78 CHRNA7 (0.42) HPGDMAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL20239526 0.78 CHRNA7 (0.42) HPGDMAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL1256199 0.77 HCAR3 (0.76) HPGDHCAR3MAPTPOLBSMN1; SMN2
SCHEMBL12349868 0.77 HCAR3 (0.57) HPGDHCAR3MAPTALDH1A1MAPK1
SCHEMBL14852264 0.77 NPC1 (0.39) MAPTALDH1A1POLBSMN1; SMN2RAB9A
SCHEMBL29751355 0.76 HCAR3 (0.55) HPGDHCAR3MAPTALDH1A1MAPK1
SCHEMBL4242678 0.74 LGALS8 (0.41) ALDH1A1MLYCD
SCHEMBL31132754 0.73 PDE2A (0.50) HPGDHCAR3MAPTALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7635702-B2 Imidazole compounds as transforming growth factor (TGF) inhibitors PFIZER INC. (US) 2009-12-22 US disclosed
EP-1542990-B1 NOVEL IMIDAZOLE COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS PFIZER PROD INC (US) 2009-06-17 EP disclosed
US-20070088037-A1 NOVEL IMIDAZOLE COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS PFIZER INC. (US) 2007-04-19 US disclosed
US-7153872-B2 Imidazole compounds as transforming growth factor (TGF) inhibitors PFIZER INC. (US) 2006-12-26 US disclosed
EP-1542990-A1 NOVEL IMIDAZOLE COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS Pfizer Products Inc. (US) 2005-06-22 EP disclosed
US-20040106608-A1 Novel imidazole compounds as transforming growth factor (TGF) inhibitors PFIZER INC 2004-06-03 US disclosed
WO-2004026859-A1 NOVEL IMIDAZOLE COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS PFIZER PRODUCTS INC. (US) 2004-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106608-A1 Novel imidazole compounds as transforming growth factor (TGF) inhibitors SMAD3, TGFBR1, TGFBR2 HPGD 973/4885HCAR3 2875/4885MAPT 1415/4885
US-20070088037-A1 NOVEL IMIDAZOLE COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS TGFBR1, SMAD3, TGFBR2 HPGD 1048/4885HCAR3 2901/4885MAPT 1204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.